MEXICO CITY, Aug. 6 -- There is growing evidence that highly active anti-retroviral therapy (HAART) has an added benefit -- it may reduce the rate of sexual transmission of HIV, researchers at the International AIDS Conference say.

If that's so -- and all the data are not in -- it will add weight to the argument that HIV treatment, now being scaled up around the world, should be rolled out more quickly.

"The wind is behind the sails for this idea," said Myron Cohen, M.D., of the University of North Carolina in Chapel Hill. More >>